Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TG Therapeutics (TGTX)
NASDAQ:TGTX
TG Therapeutics (TGTX) Ownership - Who Owns TG Therapeutics?
1,617 Followers
TG Therapeutics (TGTX) Ownership Overview
31.97% Insiders
17.66% Mutual Funds
15.46% Other Institutional Investors
34.92% Public Companies and Individual Investors
The ownership structure of TG Therapeutics (TGTX) stock is a mix of institutional, retail and individual investors. Approximately 33.12% of the company’s stock is owned by Institutional Investors, 31.97% is owned by Insiders and 34.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 20, 2024 | Sagar Lonial Director | xxxxxxxxxxxxx | $432889 |
| Mar 15, 2024 | Sagar Lonial Director | xxxxxxxxxxxxx | $79650 |
| Mar 13, 2024 | Laurence Charney Director | xxxxxxxxxxxxx | $351340 |
| Jan 08, 2024 | Laurence Charney Director | xxxxxxxxxxxxx | $333025 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $673483 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1088670 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $4258800 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $21363920 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,074,929 | Insider | 8.46% | 277,057,746 | |
| 12,947,265 | Institution | 8.38% | 274,352,545 | |
| 11,707,689 | Institution | 7.58% | 248,085,930 | |
| 7,614,855 | Insider | 4.93% | 161,358,777 | |
| 5,153,304 | Institution | 3.33% | 109,198,512 | |
| 3,609,318 | Institution | 2.34% | 76,481,448 | |
| 3,066,304 | Institution | 1.98% | 64,974,982 | |
| 1,498,658 | Institution | 0.97% | 31,756,563 | |
| 1,462,683 | Institution | 0.95% | 30,994,253 | |
| 1,440,120 | Institution | 0.93% | 30,516,143 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,707,689 | Institution | 7.58% | 248,085,930 | |
| 3,066,304 | Institution | 1.98% | 64,974,982 | |
| 1,498,658 | Institution | 0.97% | 31,756,563 | |
| 1,462,683 | Institution | 0.95% | 30,994,253 | |
| 1,440,120 | Institution | 0.93% | 30,516,143 | |
| 1,436,097 | Institution | 0.93% | 30,430,895 | |
| 718,814 | Institution | 0.47% | 15,231,669 | |
| 717,528 | Institution | 0.46% | 15,204,418 | |
| 637,896 | Institution | 0.41% | 13,517,016 | |
| 557,664 | Institution | 0.36% | 11,816,900 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,425,498 | Institution | 2.22% | 73,271,402 | |
| 3,389,112 | Institution | 2.19% | 72,493,106 | |
| 4,309,421 | Institution | 2.79% | 70,243,562 | |
| 3,473,810 | Institution | 2.25% | 56,623,103 | |
| 2,008,109 | Institution | 1.30% | 32,732,177 | |
| 1,978,658 | Institution | 1.28% | 32,252,125 | |
| 1,237,932 | Institution | 0.80% | 26,231,779 | |
| 632,084 | Institution | 0.41% | 13,520,277 | |
| 406,659 | Institution | 0.26% | 8,617,104 | |
| 519,723 | Institution | 0.34% | 8,471,485 |
FAQ
Who Owns TG Therapeutics (TGTX)?
According to the latest TipRanks data, approximately 15.46% of the company's stock is held by institutional investors, 31.97% is held by insiders, and 34.92% is held by retail investors.
What percentage of TG Therapeutics (TGTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 15.46% of TG Therapeutics (TGTX) stock is held by institutional investors.
What percentage of TG Therapeutics (TGTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.92% of TG Therapeutics (TGTX) stock is held by retail investors.
Who owns the most shares of TG Therapeutics (TGTX)?
Michael S. Weiss owns the most shares of TG Therapeutics (TGTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.